Cargando…
GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
BACKGROUND: Glypican 3 (GPC3) is a heparin sulphate proteoglycan whose expression is associated with several malignancies. However, its expression in non-small-cell lung carcinoma (NSCLC) is limited and ambiguous. This study aimed to comprehensively evaluate the expression of GPC3 in NSCLC and devel...
Autores principales: | Ning, Jing, Jiang, Shenyi, Li, Xiaoxi, Wang, Yang, Deng, Xuhong, Zhang, Zhiqiang, He, Lijie, Wang, Daqing, Jiang, Youhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194200/ https://www.ncbi.nlm.nih.gov/pubmed/34112123 http://dx.doi.org/10.1186/s12890-021-01549-9 |
Ejemplares similares
-
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021) -
GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells
por: Ning, Jing, et al.
Publicado: (2023) -
GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022) -
Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma
por: Li, Ping, et al.
Publicado: (2017) -
Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma
por: Zhang, Junxia, et al.
Publicado: (2020)